Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.250
+0.170 (8.17%)
At close: Apr 2, 2025, 4:00 PM
2.060
-0.190 (-8.44%)
After-hours: Apr 2, 2025, 7:44 PM EDT

Sunshine Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
46714305
Upgrade
Market Cap Growth
-13.95%-13.95%-51.77%-52.26%480.17%1941.74%
Upgrade
Enterprise Value
-4-6-11-26326
Upgrade
Last Close Price
2.253.00543.001280.0023380.006280.00
Upgrade
PS Ratio
0.050.170.293.33132.5573.08
Upgrade
PB Ratio
0.250.260.330.67143.04-5.47
Upgrade
P/TBV Ratio
0.290.290.350.69271.15-
Upgrade
EV/Sales Ratio
---137.9881.76
Upgrade
Debt / Equity Ratio
0.040.040.030.048.98-2.00
Upgrade
Asset Turnover
1.201.200.850.280.140.13
Upgrade
Inventory Turnover
2.852.853.491.561.821.30
Upgrade
Quick Ratio
2.152.153.393.4322.590.95
Upgrade
Current Ratio
4.114.114.483.9424.070.98
Upgrade
Return on Equity (ROE)
-22.97%-22.97%-21.04%-244.92%--
Upgrade
Return on Assets (ROA)
-12.55%-12.55%-10.57%-34.48%-93.90%-63.05%
Upgrade
Return on Capital (ROIC)
-15.68%-15.68%-13.51%-44.25%-99.36%-76.84%
Upgrade
Earnings Yield
-114.11%-85.58%-64.63%-185.03%-41.08%-53.35%
Upgrade
FCF Yield
-315.35%-236.51%-127.05%-37.65%-6.04%-12.62%
Upgrade
Buyback Yield / Dilution
-5371.73%-5668.12%----
Upgrade
Updated Nov 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q